Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2020 08:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020

HOUSTON, May 08, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to...
February 28, 2020 08:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2019 Financial Results on March 6, 2020

HOUSTON, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
November 21, 2019 11:30 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market

HOUSTON, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
November 21, 2019 08:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002

HOUSTON, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
November 15, 2019 07:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings Reports Third Quarter 2019 Financial Results

HOUSTON, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
November 08, 2019 08:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019

HOUSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
September 03, 2019 16:01 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference

HOUSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
August 26, 2019 07:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

HOUSTON, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
August 15, 2019 07:00 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings Reports Second Quarter 2019 Financial Results

HOUSTON, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
August 08, 2019 16:01 ET | Source: Bio-Path Holdings, Inc.

Bio-Path Holdings to Announce Second Quarter 2019 Financial Results on August 15, 2019

HOUSTON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...